Age and adjuvant chemotherapy use after surgery for stage III colon cancer.
about
Health disparities in colorectal cancer among racial and ethnic minorities in the United StatesMoving beyond Karnofsky and ECOG Performance Status Assessments with New TechnologiesThe impact of comorbidity on cancer and its treatmentPhysician, patient, and contextual factors affecting treatment decisions in older adults with cancer and models of decision making: a literature reviewPatterns of colorectal cancer care in the United States and Canada: a systematic reviewSecular trends in mortality from common cancers in the United States by educational attainment, 1993-2001Efficacy, compliance and reasons for refusal of postoperative chemotherapy for elderly patients with colorectal cancer: a retrospective chart review and telephone patient questionnaireDevelopment and evaluation of an information booklet/decision-making guide for patients with colorectal cancer considering therapy in addition to surgery.Decision-making in geriatric oncology: systemic treatment considerations for older adults with colon cancer.The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis.Patterns of Care for Metastatic Colorectal Cancer in Appalachia, and the Clinical, Sociodemographic, and Service Provider Determinants.Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.Assessing the quality of initial consultations regarding adjuvant colon cancer therapyExplaining black-white differences in receipt of recommended colon cancer treatmentPostoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007Is Chemotherapy or Radiation Therapy in Addition to Surgery Beneficial for Locally Advanced Rectal Cancer in the Elderly? A National Cancer Data Base (NCDB) Study.In search of the perfect comorbidity measure for use with administrative claims data: does it exist?Limits of observational data in determining outcomes from cancer therapy.Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancerVariation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicityRelative effectiveness and safety of chemotherapy in elderly and nonelderly patients with stage III colon cancer: a systematic review.The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort studyScreening mammography use and chemotherapy among female stage II colon cancer patients: a retrospective cohort study.Older breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up.Inferior oncological prognosis of surgery without oral chemotherapy for stage III colon cancer in clinical settingsAdjuvant Chemotherapy for Patients with Stage III Colon Cancer: Results from a CDC-NPCR Patterns of Care Study.Surgery and adjuvant chemotherapy use among veterans with colon cancer: insights from a California study.Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer.Hospital-based health care use correlates with incidence of adverse events among elderly Medicare patients treated in adjuvant chemotherapy trials (Alliance 70802).Comorbidities, functional limitations, and geriatric syndromes in relation to treatment and survival patterns among elders with colorectal cancer.Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendationsMeasuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participantsChallenges and opportunities for developing and implementing incentives to improve health-related behaviors in older adultsValidation of electronic data on chemotherapy and hormone therapy use in HMOs.Reasons physicians do not recommend and patients refuse adjuvant chemotherapy for stage III colon cancer: a population based chart review.Racial differences in the receipt of bowel surveillance following potentially curative colorectal cancer surgeryAssociations of Demographic and Socioeconomic Factors with Complete Treatment and Follow-up of Colon Cancer.Geriatric Oncology Research in the Cooperative Groups: A Report of a SIOG Special Meeting.Patient, Physician and Contextual Factors Are Influential in the Treatment Decision Making of Older Adults Newly Diagnosed with Symptomatic Myeloma.Race/ethnicity-based concerns over understanding cancer diagnosis and treatment plan.
P2860
Q26749003-423A1D87-5CB7-41B5-985F-3B917448042AQ26749492-508988BF-1779-4EB3-AA8D-0A81A86C5DC2Q26764935-B59115DA-A8D1-48F1-87BB-60AAC419C5D1Q26851812-2E92779D-D4AC-4434-9484-77774B806F36Q26863029-DA6F5317-AA1B-41F6-8A1F-88AF620B4A8CQ28384895-88D29593-501B-4F7D-B58F-270DF6C324FEQ28486580-336AC733-675B-4D0D-9CD3-C77ED1E39677Q30233112-0838A2E4-B5DE-4799-8D3A-5073057507FAQ30244769-E0F71A80-F820-4D94-9F24-D6C4B206CEE5Q30245342-8A0E297B-9BD9-42DA-8687-BE73DC2E63A0Q30278908-A7CB5338-C480-4CFE-9FB4-E329F6B1FD64Q30418160-E2D705B2-2F49-4606-9BED-5460B1580605Q30435841-C546A346-6683-4498-94A2-9906F69C2CA3Q30502576-3B88B7F2-4C2B-4209-B62C-55C38B13F636Q30744596-B5933254-B971-47CF-BA60-1BBDB362FFB7Q31023316-EDE40BFA-3AE0-4699-B554-E3CED2714E15Q31049563-B0286F14-1C07-44CF-8B66-24EBBCAE1B62Q31153256-D4943DAA-AE7C-421D-869E-427E3BBB416EQ33345743-D86F8243-C517-459E-B637-B5BD6CB07641Q33367028-4EE31A61-5018-4B40-9463-017115912DD2Q33405177-A522E193-4865-4ED0-92F9-059A10318E63Q33432354-290E7E47-C99C-4493-9405-36787E041C86Q33559153-BD2BAD71-7366-43EA-B97C-C3D429DA982FQ33627703-9E985115-4206-4C7A-A600-E8AC354225DFQ33646009-289C3A6B-3F62-4D67-834A-5EC95F14C5E0Q33860245-ACA9BC24-0A91-4696-981A-46C6F2065708Q33897653-C298B427-AD1C-48EB-879C-C15F2F3D82A8Q33946721-63FF19D0-3493-4C19-B1FC-18DBABAB2A62Q33992552-BD0999C4-F6A1-44B7-A95A-46392869283EQ33997290-F87FDFFC-ABB6-488F-9673-DBE72BED4A52Q34031134-F351930B-693A-477E-B09A-263CF6062E8AQ34150896-74D95E35-CE4E-4542-BF2E-E4E12199F415Q34157446-4DDD90B3-95EC-4C04-B7FB-D0DCB81C6E03Q34244526-8A7682B9-4661-4822-8A52-60BAD6BBD610Q34296147-7104CF6A-7D23-4924-80B9-048573D4D374Q34336196-F1F8B061-E9F4-4618-A678-0A4154C05F0EQ34405267-630D6384-A699-4523-830C-970AA422BDC7Q34460029-48189B8E-F4C8-46EA-A61C-E5E12E3052D5Q34781514-735A0A41-3602-4796-B4CF-728A1A6D61D8Q34817079-AA2A4AA8-7226-45D1-AB3E-7A58823ACA18
P2860
Age and adjuvant chemotherapy use after surgery for stage III colon cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Age and adjuvant chemotherapy use after surgery for stage III colon cancer.
@en
Age and adjuvant chemotherapy use after surgery for stage III colon cancer.
@nl
type
label
Age and adjuvant chemotherapy use after surgery for stage III colon cancer.
@en
Age and adjuvant chemotherapy use after surgery for stage III colon cancer.
@nl
prefLabel
Age and adjuvant chemotherapy use after surgery for stage III colon cancer.
@en
Age and adjuvant chemotherapy use after surgery for stage III colon cancer.
@nl
P2093
P2860
P356
P1476
Age and adjuvant chemotherapy use after surgery for stage III colon cancer.
@en
P2093
P2860
P304
P356
10.1093/JNCI/93.11.850
P407
P577
2001-06-01T00:00:00Z